CurcuminImmediate hypersensitivity reaction: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1665卷 / 1期

关键词：

D O I：

10.1007/s40278-017-34660-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[31] TocilizumabImmediate hypersensitivity reaction: 5 case reports
Reactions Weekly, 2015, 1535 (1) : 203 - 203
[32] LenalidomideDelayed hypersensitivity reaction: 5 case reports
Reactions Weekly, 2014, 1532 (1) : 137 - 137
[33] IbuprofenInfusion site pain and systemic hypersensitivity reaction: 2 case reports
Reactions Weekly, 2016, 1599 (1) : 115 - 115
[34] RituximabAnaphylaxis and infusion-related hypersensitivity reaction: 2 case reports
Reactions Weekly, 2021, 1862 (1) : 432 - 432
[35] Etoposide/etoposide phosphate.Hypersensitivity reaction: 2 case reports
Reactions Weekly, 2014, 1530 (1) : 97 - 97
[36] Cetuximab/cisplatinAllergic hypersensitivity reaction and reversible tinnitus: 2 case reports
Reactions Weekly, 2017, 1662 (1) : 93 - 93
[37] FlucloxacillinDelayed hypersensitivity in the form of DRESS syndrome and systemic immediate hypersensitivity reaction: 2 case reports
Reactions Weekly, 2020, 1825 (1) : 111 - 111
[38] InfliximabInfusion reaction and delayed hypersensitivity reaction: 3 case reports
Reactions Weekly, 2019, 1753 (1) : 196 - 196
[39] Multiple drugsImmediate hypersensitivity reaction: 11 case reports
Reactions Weekly, 2020, 1835 (1) : 270 - 270
[40] OcrilateType IV hypersensitivity reaction: 3 case reports
Reactions Weekly, 2017, 1658 (1) : 357 - 357

← 1 2 3 4 5 →